FARMACOLOGÍA
Departamento
Queen Mary University of London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Queen Mary University of London (8)
2023
-
Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response
Biomedicine and Pharmacotherapy, Vol. 163
2017
-
Visceral and somatic pain modalities reveal NaV1.7-independent visceral nociceptive pathways
Journal of Physiology, Vol. 595, Núm. 8, pp. 2661-2679
2012
-
The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine
European Journal of Nutrition, Vol. 51, Núm. 3, pp. 365-374
2010
-
Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds
Journal of Neuroscience, Vol. 30, Núm. 32, pp. 10860-10871
2006
-
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance
European Journal of Immunology, Vol. 36, Núm. 6, pp. 1374-1385
-
The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells
Biochemical and Biophysical Research Communications, Vol. 346, Núm. 3, pp. 919-925
2005
-
Role of toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscles
Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 12, pp. 4637-4642
2004
-
Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I 2: Investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues
Journal of Pharmacology and Experimental Therapeutics, Vol. 310, Núm. 2, pp. 642-647